Same Drug Class

Methotrexate vs Upadacitinib

Methotrexate vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Methotrexate and Upadacitinib.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5; Upadacitinib — C17H19F3N6O.

Molecular Weight: Methotrexate — 454.4400 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Methotrexate — Small molecule; Upadacitinib — Small molecule.